Sandra Donnelly

456 total citations
8 papers, 360 citations indexed

About

Sandra Donnelly is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sandra Donnelly has authored 8 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology. Recurrent topics in Sandra Donnelly's work include Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). Sandra Donnelly is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). Sandra Donnelly collaborates with scholars based in United States. Sandra Donnelly's co-authors include John M. Kirkwood, Sanjiv S. Agarwala, Janice Shipe-Spotloe, Catherine Bender, Ahmad A. Tarhini, Howard Edington, Dorothea Becker, David J. Tweardy, Daniel L. Farkas and John Leo Abernethy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy and Molecular Medicine.

In The Last Decade

Sandra Donnelly

8 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Donnelly United States	8	196	142	122	31	29	8	360
Glenn Whiteside New Zealand	7	199 1.0×	153 1.1×	121 1.0×	37 1.2×	27 0.9×	7	389
Stefan A. Cohen United States	13	152 0.8×	209 1.5×	95 0.8×	25 0.8×	54 1.9×	21	420
Diederik van Bodegom United States	7	101 0.5×	57 0.4×	185 1.5×	42 1.4×	42 1.4×	10	360
Paolo Marolla Italy	10	170 0.9×	39 0.3×	77 0.6×	44 1.4×	70 2.4×	16	322
Jennifer Dine United States	7	162 0.8×	71 0.5×	114 0.9×	28 0.9×	39 1.3×	14	309
Yoshitaka Kikukawa Japan	8	143 0.7×	128 0.9×	169 1.4×	42 1.4×	51 1.8×	20	405
Sarah Sloot Netherlands	10	201 1.0×	57 0.4×	159 1.3×	13 0.4×	21 0.7×	15	388
Biljana Smiljanovic Germany	9	65 0.3×	158 1.1×	103 0.8×	17 0.5×	20 0.7×	17	313
Jun Hong United States	13	156 0.8×	105 0.7×	194 1.6×	23 0.7×	72 2.5×	18	400
Larisa Ryvo Israel	8	239 1.2×	76 0.5×	68 0.6×	10 0.3×	64 2.2×	13	312

Countries citing papers authored by Sandra Donnelly

Since Specialization

Citations

This map shows the geographic impact of Sandra Donnelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Donnelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Donnelly more than expected).

Fields of papers citing papers by Sandra Donnelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Donnelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Donnelly. The network helps show where Sandra Donnelly may publish in the future.

Co-authorship network of co-authors of Sandra Donnelly

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Donnelly. A scholar is included among the top collaborators of Sandra Donnelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Donnelly. Sandra Donnelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Islam, Mohammed F., Reginald F. Frye, Thomas J. Richards, et al.. (2002). Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs.. PubMed. 8(8). 2480–7. 49 indexed citations

2.

Kirkwood, John M., Catherine Bender, Sanjiv S. Agarwala, et al.. (2002). Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy. Journal of Clinical Oncology. 20(17). 3703–3718. 145 indexed citations

3.

Kirkwood, John M., Daniel L. Farkas, Arup Chakraborty, et al.. (1999). Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.. PubMed. 5(1). 11–20. 40 indexed citations

4.

Kirkwood, John M., Daniel L. Farkas, Arup Chakraborty, et al.. (1999). Systemic Interferon-α (IFN-α) Treatment Leads to Stat3 Inactivation in Melanoma Precursor Lesions. Molecular Medicine. 5(1). 11–20. 38 indexed citations

5.

Donnelly, Sandra. (1998). Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma.. PubMed. 25(5). 921–7. 20 indexed citations

6.

Kirkwood, John M., John Wilson, Theresa L. Whiteside, Sandra Donnelly, & Ronald B. Herberman. (1997). Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma. Cancer Immunology Immunotherapy. 44(3). 137–149. 16 indexed citations

7.

Smith, David C., Stanton L. Gerson, Sandra Donnelly, et al.. (1996). Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.. PubMed. 2(7). 1129–34. 31 indexed citations

8.

Wang, Yi‐Ping, Uma Rao, R. Mascari, et al.. (1996). Molecular analysis of melanoma precursor lesions.. PubMed. 7(12). 1733–40. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact